anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
There is no specific antidote for trazodone hydrochloride overdose.

Treatment should consist of those general measures employed in the management of overdosage with any drug effective in the treatment of major depressive disorder.

Ensure an adequate airway, oxygenation and ventilation. Monitor cardiac rhythm and vital signs.

General supportive and symptomatic measures are also recommended. Induction of emesis is not recommended. Gastric lavage with a large bore orogastric tube with appropriate airway protection, if needed, may be indicated if performed soon after ingestion, or in symptomatic patients. Activated charcoal should be administered. Forced diuresis may be useful in facilitating elimination of the drug.

In managing overdosage, consider the possibility of multiple drug involvement. The physician should consider contacting a poison control center for additional information on the treatment of any overdose.
PURPOSE: To evaluate the role of M2 macrophages in subconjunctival fibrosis after silicone implantation (SI) and investigate the underlying mechanisms.
MATERIALS AND METHODS: A model of subconjunctival fibrosis was established by SI surgery in rabbit eyes. M2 distribution and collagen deposition were evaluated by histopathology. The effects of M2 cells on the migration (using wound-scratch assay) and activation (by immunofluorescence and western blotting) of human Tenon's fibroblasts (HTFs) were investigated.
RESULTS: There were more M2 macrophages (CD68+/CD206+ cells) occurring in tissue samples around silicone implant at 2 weeks postoperatively. Dense collagen deposition was observed at 8 weeks after SI. In vitro experiment showed M2 expressed high level of CD206 and transforming growth factor-β1 (TGF-β1). The M2-conditioned medium promoted HTFs migration and the synthesis of collagen I and fibronectin. Meanwhile, M2-conditioned medium increased the protein levels of TGF-β1, TGF-βR II, p-Smad2/3, yes-associated protein (YAP), and transcriptional coactivator with PDZ-binding motif (TAZ). Verteporfin, a YAP inhibitor, suppressedTGF-β1/Smad2/3-YAP/TAZ pathway and attenuated M2-induced extracellular matrix deposition by HTFs.
CONCLUSIONS: TGF-β1/Smad2/3-YAP/TAZ signalling may be involved in M2-induced fibrotic activities in HTFs. M2 plays a key role in promoting subconjunctival fibrosis and can serve as an attractive target for anti-fibrotic therapeutics.
Patients will receive Doxil at the standard dose of 20 mg/m2 IV for the 1st cycle. On the 2nd cycle of Doxil, the first patient will receive Doxil at 40% of standard dose or 8 mg/m2 (dose level 1) IV over one hr. 15 mn after the 2nd and subsequent cycles of Doxil, PSC 833 will be given at 2 mg/kg for 2 hrs. Simultaneously, a 72 hour CIVI of PSC 833 will be started with the loading dose. If no DLT occurs, then a double dose escalation of Doxil (dose levels 3, 5, 7 ) will be given to the same patient in the subsequent cycles until DLT occurs. On the 2nd cycle, Doxil will be given at the next dose level above the starting dose tolerated by the first patient. If no DLT occurs, a double dose escalation will also be done for the subsequent cycles (dose levels 5, 7, 9). The single-patient-cohort will terminate when a patient experiences DLT or when two episodes of grade 2 toxicity occur. At that point patients will be enrolled into cohorts of 3 patients to determine the MTD.
Provided is a pharmaceutical composition containing Piper nigrum extracts or amide compounds isolated from Piper nigrum, which have effects of inhibiting ICAM-1(Intercellular adhesion molecule-1) and LFA-1(Leukocyte function associated antigen-1)-mediated cell adhesion. A pharmaceutical composition for treating inflammation diseases comprises Piper nigrum extracts or amide compounds isolated from Piper nigrum. The Piper nigrum extracts are extracted by water, C1-C4 low alcohol or mixed solvent thereof. The low alcohol indicates methanol, ethanol or butanol. A solvent extract of the Piper nigrum is fractioned by an extraction solvent such as hexane, chloroform and ethylacetate. The Piper nigrum extracts contain compounds represented by the formula 1 to 4 or one of compounds represented by the formula 1 to 4.
The Control Group will be implanted with the aura6000 System and receive treatment as-usual, (i.e. any non-PAP, non-surgical OSA treatment including oral appliances and positional devices being used prior to enrollment in the study) until 14 days (washout period) prior to the Month 4 visit. At the Month 4 + 1 day follow-up visit, subjects in the Control Group will have therapy turned ON for the duration of the study.
ETHNOPHARMACOLOGICAL RELEVANCE: Viola yedoensis Makino (VYM) is a traditional Chinese herbal medicine widely distributed in China. It has many pharmacological effects such as anti-inflammatory, immune regulation and anti-oxidation. However, the protective effect of VYM on the spleen and thymus of broilers induced by heat stress has rarely been reported.
AIM OF THE STUDY: We established a heat stress model of broilers to explore the protective effect of VYM on spleen and thymus of broilers.
MATERIALS AND METHODS: In this experiment, a heat stress model was made by adjusting the feeding temperature of broilers. The protective effect of VYM on the spleen and thymus of heat-stressed broilers were evaluated by detecting immune organ coefficient, histological observation, Enzyme-Linked Immunosorbent Assay, production of antioxidant enzymes and peroxides, TUNEL Staining, Quantitative Real-time PCR.
RESULTS: In this study, 60 healthy male AA broilers were divided into 6 groups: Control, 4.5% VYM, HS, HS + 0.5% VYM, HS + 1.5% VYM, HS + 4.5% VYM. After 42 days of feeding, serum, spleen and thymus were collected for detection and analysis. The study revealed that heat stress can lead to pathological damage in the spleen and thymus of broilers, reduce the content of immunoglobulin and newcastle disease (ND), infectious bursal disease (IBD) antibody levels, increase the expression of inflammatory factors IL-1β, INF-γ, heat shock 70 kDa protein (HSP70), heat shock 90 kDa protein (HSP90). Heat stress inhibits the activity of antioxidant enzymes CAT and SOD, promotes the production of MDA, and then lead to oxidative damage of the spleen and thymus. In addition, apoptotic cells and the ratio of Bax/Bcl-2 was increased. However, the addition of VYM to the feed can alleviate the adverse effects of heat stress on the spleen and thymus of broilers.
CONCLUSIONS: This study showed that the addition of VYM to the diet could inhibit oxidative stress and apoptosis, and reduce the inflammatory damage of heat stress on the spleen and thymus of broilers. This study provides a basis for further exploring the regulatory role of VYM in heat stress-induced immune imbalance in broilers. In addition, this study also provides a theoretical basis for the development of VYM as a feed additive with immunomodulatory effects.
In the US, 92-96% and 43-63% of men and women do not meet recommended intakes for αT and PQ, respectively. Dietary recommendations strongly encourage a diet rich in fruits and vegetables to meet dietary αT and PQ requirements. However, αT and PQ bioavailability from most plant foods is quite poor, thereby emphasizing a need for effective food pairings that can enhance the absorption and promote adequate status of these health-promoting nutrients. The objective of this application is to use deuterium-labeled spinach (containing stable isotopes of αT and PQ) to validate eggs as a dietary tool to improve αT and PQ bioavailability directly from a model plant food, and hence achieve nutrient adequacy. Our hypothesis is that the bioavailability of αT and PQ from deuterium-labeled spinach will be potentiated by egg intake in a dose-dependent manner by increasing their secretion in intestinal-derived chylomicrons.

To test this, our specific aim is to assess egg-mediated improvements in αT and PQ bioavailability by conducting a randomized cross-over pharmacokinetic study in healthy men and women. In Study Arms 1-4, participants will ingest deuterium-labeled spinach (containing 2 mg αT and 500 μg PQ) with 0, 1, 2, or 3 hardboiled eggs (containing 0, 4.8, 9.6, or 14.4 g total fat, respectively). In Study Arm 5, participants will ingest spinach alone followed by 1 egg 3-hours later. In Study Arm 6, participants will ingest spinach with 1 egg followed by another egg 3-hours later. Thus, Study Arms 1-4 will test the dose-dependent effects of eggs on nutrient bioavailability and Study Arms 5-6 (with comparison to Study Arms 1 and 2) will test the 'timing'-dependent effects of eggs on nutrient bioavailability. Eucaloric diets will be controlled for αT and PQ intakes for 3 d prior to and during the initial 24 h of each trial to minimize heterogeneity of pharmacokinetic responses. Spinach-derived deuterium-labeled αT and PQ will be measured in plasma and isolated chylomicrons collected at timed intervals from 0-72 h post-meal ingestion, and biomarkers of antioxidant status and oxidative distress will be assessed at baseline (0 h) of each trial. Outcomes from this study are expected to demonstrate a dose- and time-dependent function of eggs to increase deuterium-labeled αT and PQ bioavailability (based on AUC0-72 h, Cmax, and % estimated absorption).

The rationale for this study is that, by establishing the efficacy of eggs to potentiate plant-derived fat-soluble nutrient bioavailability, a strong framework will exist for an easily implementable health-promoting food pairing strategy to overcome malnutrition of αT and PQ.
A quasi-experimental study comparing the mixing and discard methods of laboratory specimen techniques in an adult acute care setting was conducted over a 30-month period. Primary end points were delta hemoglobin (Hgb) and transfusion rates. Secondary end points were redraws related to hemolysis and erroneous results, noting central venous access device (CVAD) type. Primary objectives included the comparison of hospital-acquired anemia and transfusion rates utilizing Hgb and venous sampling methods as part of a patient blood management (PBM) program. Secondary objectives tracked the type of CVAD used to acquire venous specimens and the impact on hemolysis rates or erroneous results. Considerations include exploring the benefits of utilizing the mixing method related to cost savings. In summary, the mixing versus discard method eliminates wasting blood to reduce hospital-acquired anemia as part of a PBM program. CVAD type did not influence hemolysis rates or impact erroneous results. The mixing method is easy to implement in any health care setting. Cost savings are feasible by elimination of external venous or arterial blood management protection devices. Removal of add-on devices supports standards by decreasing access points to reduce infection risk. Results, although inconclusive to superiority, demonstrated noninferiority and encouraged consideration of the mixing method for laboratory specimen collection.
PURPOSE: Pigment mixtures containing at least two components are provided. which component A being Al2O3 flakes coated with one or more metals, metal oxides and/or metal sulfides and component B being special-effect pigments, and to their use in varnishes, paints, printing inks, plastics and cosmetic formulations. CONSTITUTION: A Al2O3 flakes are provided with one or more metal oxide layers. Examples of suitable metal oxides or metal oxide mixtures are titanium dioxide) zirconium oxide, zinc oxide, iron oxides ( Fe2O3 and/or Fe3O4) and/or chromium oxide, especially TiO2 and/or Fe2O3. The Al2O3 flakes can be coated in the same way as pearl lustre pigments. Coatings with a metal oxide may be accomplished by any known methods, such as hydrolysis of a metal salt by heating or alkali, which deposits hydrated metal oxide, followed by calcination. Al2O3 flakes can also be coated with one or more layers of a metal or metal alloy selected e.g. from chromium, nickel, silver, bismuth, copper, tin, or hastalloy. Al2O3 flakes coated with a metal sulfide are coated with sulfides e.g. of tungsten, molybdenum, cerium, lanthanum or rare earth elements.
PURPOSE:A remedy for hemorrhoids containing linoleic acid, linolenic acid, eicosapentaenoic acid, etc. as an active ingredient. CONSTITUTION:0.1-100wt% linoleic acid, linolenic acid, eicosapentaenoic acid and their glycerin esters is blended with an antioxidant substance (e.g., dl-alpha- tocopherol, nordihyroguaiaretic acid, buthylhydroxyanisole, etc.), to give a remedy for hemorrhoids. The remedy can be mixed with a drug having analgesic action, antipruritic action, sterilizing action, anti-inflammatory action, locally styptic action, etc. A suppository, ointment, spray using an oil base, etc. may be used as a dosage form for administration. The action of the active ingredient is considered to improve blood circulation in the varix of the surrounding parts of the anus, which is the cause of hermorrhoids.
Participants will come into the clinic in a fasting state to receive the Product B® IsaGenesis®, which will be a one time dose of the liquid-gel formulation contained in 2 capsules, 1280 mg per capsule. After a washout period of 7 days, they will then come back to the clinic in a fasting state to receive the IsaGenesis®. This will be given for a comparison in a one time dose of the dried powder extract contained in 2 capsules; 1070 mg per capsule.
PURPOSE:To provide a remedy for hepatopathy, effective to promote the absorption of a branched-chain amino acid in oral administration, by mixing a garlic extract component to a branched-chain amino acid. CONSTITUTION:The objective remedy contains a branched-chain amino acid or its salt in combination with a garlic extract component. It is proposed that the hepatic encephalopathy is caused by the pseudoneurotransmission by amino acid dysbolism. The amino acid pattern in blood is normalized by increasing the ratio of branched amino acid (e.g. leucine, isoleucine, etc.) to aromatic amino acid (e.g. phenylalanine, tyrosine, etc.) in blood. Although the administration of branched chain amino acid is effective for the prevention of encephal opathy, however, there are problems of the cost of preparation and the pain of patient in the case of administration of the amino acid as an amino acid transfusion. The peroral administration of the amino acid gives low transferrability to blood, and causes problems by long-term administration. The intestinal absorption rate of the branched amino acid can be improved by the addition of a garlic extract component, and accordingly, the transferrability to blood can be improved, the ratio of branched-chain amino acid to aromatic amino acid in blood is increased, and a medicinal drug effective for the remedy of encephal opathy can be produced.
An anti-hypotensive formulation comprising an essentially arginine-free or low arginine (less than about 0.1%, most preferably, about 0.01%) containing mixture of amino acids is provided. The invention in particular embodiments of the anti-hypotensive formulation includes ornithine, citrulline or both. A method for prophylaxis and treatment of systemic hypotension in an animal is provided. Most particularly, a method for treating hypotension caused by nitric oxide synthesis through administering a low or essentially arginine-free parenteral formulation to an animal, so as to reduce or eliminate nitric oxide synthesis is described. A method for treating an animal in septic shock is also disclosed, comprising administering to the animal an anti-hypotensive formulation comprising a mixture of amino acids, which is essentially arginine free. Prophylaxis or treatment of systemic hypotension, particularly that hypotension incident to chemotherapeutic treatment with biologic response modifiers, such as tumor necrosis factor or interleukin-1 or -2, may be accomplished through the administration of the defined anti-hypotensive formulations until physiologically acceptable systolic blood pressure levels are achieved in the animal. Treatment of an animal for septic shock induced by endotoxin may also be accomplished by administering to the animal the arginine-free formulations described.
Acute respiratory distress syndrome (ARDS) is a serious complication following cardiac surgery mainly associated with the use of cardiopulmonary bypass (CPB), which could increase the risk of mortality and morbidity. This study investigated the association of regional oxygen saturation (rSO2) during CPB with postoperative outcomes, including respiratory function. Patients who underwent cardiac surgery with CPB from 2015 to 2019 were included. Near-infrared spectroscopy was used to monitor rSO2 at the forehead, abdomen, and thighs throughout the surgery. Postoperative markers associated with CPB were assessed for correlations with PaO2/FiO2 (P/F) ratios at intensive care unit (ICU) admission. Postoperative lung injury (LI) was defined as moderate or severe ARDS based on the Berlin criteria, and its incidence was 29.9% (20/67). On multiple regression analysis, the following were associated with P/F ratios at ICU admission: vasoactive-inotropic scores at CPB induction (P = 0.03), thigh rSO2 values during CPB (P = 0.04), and body surface area (P < 0.001). A thigh rSO2 of 71% during CPB was significantly predictive of postoperative LI with an area under the curve of 0.71 (P = 0.03), sensitivity of 0.70, and specificity of 0.68. Patients with postoperative LI had longer ventilation time and ICU stays. Thigh rSO2 values during CPB were a potential predictor of postoperative pulmonary outcomes.
PURPOSE:To obtain a tablet having a clear carved seal, by applying a substance having color tone different from that of the protrusion part of the carved seal of the tablet having a carved seal to the dent part of the carved seal, and, if necessary, covering the dent part of the carved seal with a film-forming solution. CONSTITUTION:A tablet having a carved seal, preferably the slightly covered tablet, is covered with a substance having color tone different from that of the protrusion part of the carved seal by using a coating pan, etc. Naturally a substance which has been used for forming a film can be used as the substance, and an additive ordinarily useful for tablet can be used without limiting it specifically. It is usually blended with a dyestuff, etc. having a color tone different from that of the protrusion part of the carved seal. An excess amount of the substance can be removed by screening by a sieve, grinding by a brush, etc. After that, if necessary, the tablet is covered with a film-forming solution such as water-soluble, enteric solution, or solution soluble in the stomach, to give a tablet having a clear carved seal.
Patients receive everolimus PO daily and continue their most recent hormone therapy. Patients achieving disease progression receive trastuzumab IV over 30-90 minutes once every 3 weeks in combination with everolimus and hormone therapy.
The invention relates to compound traditional Chinese medicine acne gel and a preparation method of the compound traditional Chinese medicine acne gel. The compound traditional Chinese medicine acne gel comprises 5-20 parts of salviae miltiorrhizae, 10-30 parts of radix scutellariae, 10-35 parts of hedyotis diffusa, 15-35 parts of wild chrysanthemum, 5-20 parts of flos carthami, 10-25 parts of cynanchum atratum, 5-15 parts of liquorice, 5-20 parts of carbomer, 10-40 parts of triethanolamine, 15-40 parts of glycerol, 0.5-2 parts of ethylparaben, 30-70 parts of propylene glycol and 50-300 parts of distilled water. According to the compound traditional Chinese medicine acne gel, the gel is extracted from multiple kinds of Chinese traditional medicine, and chemical substances, such as a hormone and a pigment, harmful to the skin are not contained. Results of animal stimulation tests show that the compound traditional Chinese medicine acne gel is gentle to the skin and free of stimulation to the skin and side effects. The compound traditional Chinese medicine acne gel has the advantages of being easy to spread, fresh, cool, free of an oily feel, good in adhesiveness and homogeneity, easy to carry and the like. The compound traditional Chinese medicine acne gel remarkably improves the medicine utilization ratio. The combination of medicine of the prescription of the compound traditional Chinese medicine acne gel enables inflammation diminishment and recovery of the injured skin to be conducted simultaneously and the effects that acne is fully cured and acne post-inflammatory hyperpigmentation is eliminated as soon as possible are achieved.
OBJECTIVE: To determine the association between environmental tobacco smoke exposure and growth parameters of infants.
METHODS: The observational, comparative study was done in rural areas of the Al-Karkh sector of Baghdad, Iraq, from December 2021 to March 2022 after approval from the ethics review committee of the College of Dentistry, University of Baghdad, and comprised mothers aged 20-35 years having infants aged up to one year. Those exposed to environmental tobacco smoke were in group A, while non-exposed mothers were in group B. Along with sociodemographic data, a second-hand smoke exposure scale was used. Weight-for-height, height-for-age and weightfor- age indices, as well as head circumference values, were used to measure growth parameters. Data was analysed using SPSS 22.
RESULTS: Of the 150 mothers, 67(44.7%) were in group A with mean age 27.8±4.7 years and 83(55.3%) were in group B with mean age 26,1±4.6 years. The mean age of the children was 9.4±3.1 years in group A and 9.2±2.3 years in group B. Husband was the primary source of smoking at home 55(82.08%). When it came to exposure duration, 58(86.57%) had been exposed for years and 9(13.43 %) for months. The mean Z-score for all growth measurements was higher in group B infants compared to group A (p<0.05) except weight-for-height (p>0.05).
CONCLUSIONS: Mothers' exposure to environmental tobacco smoke was found to have a significant harmful effect on the growth parameters of infants.
Active ingredient: Celecoxib, 200 mg. Pharmacotherapeutic group: Coxibs. ATC code: M01AH.
Study participants randomized to this arm will receive assigned doses of padsevonil twice daily. On Day 8 padsevonil will be administered in the morning, and placebo will administered in the evening.
Elderly subjects will be recruited from a residential-care complex in Zwolle, the Netherlands. All subjects will be asked to fill in the Groningen Frailty Index. We aim to select patients with varying GFI scores to ensure that we include patients with different degrees of frailty. The participating subjects will be asked to wear the DynaPort MicroMod during six hours. Two research employees will observe all activities of the participating subjects in their home environment. The participant will be instructed to act like it is a normal/usual day. Every 5 minutes the type of activity at that moment and movement intensity of the last 5 minutes (METs scale) is manually entered onto a case report form (CRF) by the two employees. The timing has to be exact in order to compare the data to the data of the DynaPort MicroMod. Type of activity is described as well as categorised into lying, sitting, standing or walking. Movement intensity is categorised according to a MET-value (Metabolic Equivalent of Task).

Sensitivity, specificity, and percentage of overall agreement will be calculated for each type of activity (standing, sitting, lying, walking) and for intensity. The primary analysis will be the comparison between walking and not walking (lying, sitting or standing). An overall agreement/sensitivity/specificity of 90% or higher is considered as sufficient agreement. The Bland and Altman method will also be used as multiple observations are recorded per patient, the limits of agreement will also be calculated with the Bland and Altman method for repeated measures.